Wikidata

(Q62025521)

English

Observational Study on the Use of Akynzeo® in Patients Receiving HEC

clinical trial

In more languages

Statements

short name
EVOLVE_CINV (English)
0 references
title
A Phase IV, Real World Observational Study On The Use Of Akynzeo® (Netupitant/Palonosetron) For The Prevention Of Nausea and Vomiting in Oncology Patients Receiving Highly Emetogenic Chemotherapy (HEC) Over Multiple Cycles. (English)
0 references
medical condition
nausea
0 references
vomiting
0 references
country
Canada
0 references
start time
3 October 2018
0 references
end time
30 January 2020
0 references
number of participants
200
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62025521&oldid=2149146139"